These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes. Castillero E, Alamdari N, Lecker SH, Hasselgren PO. Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982 [Abstract] [Full Text] [Related]
3. Glucocorticoids impair bone formation of bone marrow stromal stem cells by reciprocally regulating microRNA-34a-5p. Kang H, Chen H, Huang P, Qi J, Qian N, Deng L, Guo L. Osteoporos Int; 2016 Apr; 27(4):1493-1505. PubMed ID: 26556739 [Abstract] [Full Text] [Related]
4. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells. Matsumoto Y, Otsuka F, Takano M, Mukai T, Yamanaka R, Takeda M, Miyoshi T, Inagaki K, Sada KE, Makino H. Mol Cell Endocrinol; 2010 Aug 30; 325(1-2):118-27. PubMed ID: 20638987 [Abstract] [Full Text] [Related]
5. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes. Shalhoub V, Conlon D, Tassinari M, Quinn C, Partridge N, Stein GS, Lian JB. J Cell Biochem; 1992 Dec 30; 50(4):425-40. PubMed ID: 1469073 [Abstract] [Full Text] [Related]
6. Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics. Ogston N, Harrison AJ, Cheung HF, Ashton BA, Hampson G. Steroids; 2002 Oct 30; 67(11):895-906. PubMed ID: 12234625 [Abstract] [Full Text] [Related]
7. Thiazolidinedione effects on glucocorticoid receptor-mediated gene transcription and differentiation in osteoblastic cells. Johnson TE, Vogel R, Rutledge SJ, Rodan G, Schmidt A. Endocrinology; 1999 Jul 30; 140(7):3245-54. PubMed ID: 10385421 [Abstract] [Full Text] [Related]
8. Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not glucocorticoid-induced suppression of bone formation. Liu P, Baumgart M, Groth M, Wittmann J, Jäck HM, Platzer M, Tuckermann JP, Baschant U. Sci Rep; 2016 Aug 24; 6():32112. PubMed ID: 27554624 [Abstract] [Full Text] [Related]
9. MURF1 deficiency suppresses unloading-induced effects on osteoblasts and osteoclasts to lead to bone loss. Kondo H, Ezura Y, Nakamoto T, Hayata T, Notomi T, Sorimachi H, Takeda S, Noda M. J Cell Biochem; 2011 Dec 24; 112(12):3525-30. PubMed ID: 21866567 [Abstract] [Full Text] [Related]
10. Influence of glucocorticoids on human osteoclast generation and activity. Sivagurunathan S, Muir MM, Brennan TC, Seale JP, Mason RS. J Bone Miner Res; 2005 Mar 24; 20(3):390-8. PubMed ID: 15746983 [Abstract] [Full Text] [Related]
11. Glucocorticoid receptor and Histone deacetylase 6 mediate the differential effect of dexamethasone during osteogenesis of mesenchymal stromal cells (MSCs). Rimando MG, Wu HH, Liu YA, Lee CW, Kuo SW, Lo YP, Tseng KF, Liu YS, Lee OK. Sci Rep; 2016 Nov 30; 6():37371. PubMed ID: 27901049 [Abstract] [Full Text] [Related]
12. miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway. Li H, Li T, Fan J, Li T, Fan L, Wang S, Weng X, Han Q, Zhao RC. Cell Death Differ; 2015 Dec 30; 22(12):1935-45. PubMed ID: 26206089 [Abstract] [Full Text] [Related]
13. Human molecular genetic and functional studies identify TRIM63, encoding Muscle RING Finger Protein 1, as a novel gene for human hypertrophic cardiomyopathy. Chen SN, Czernuszewicz G, Tan Y, Lombardi R, Jin J, Willerson JT, Marian AJ. Circ Res; 2012 Sep 14; 111(7):907-19. PubMed ID: 22821932 [Abstract] [Full Text] [Related]
14. The role of glucocorticoids and prostaglandin E2 in the recruitment of bone marrow mesenchymal cells to the osteoblastic lineage: positive and negative effects. Scutt A, Bertram P, Bräutigam M. Calcif Tissue Int; 1996 Sep 14; 59(3):154-62. PubMed ID: 8694891 [Abstract] [Full Text] [Related]
15. MicroRNA-17/20a inhibits glucocorticoid-induced osteoclast differentiation and function through targeting RANKL expression in osteoblast cells. Shi C, Qi J, Huang P, Jiang M, Zhou Q, Zhou H, Kang H, Qian N, Yang Q, Guo L, Deng L. Bone; 2014 Nov 14; 68():67-75. PubMed ID: 25138550 [Abstract] [Full Text] [Related]
16. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway. Wang XJ, Xiao JJ, Liu L, Jiao HC, Lin H. Biosci Rep; 2017 Dec 22; 37(6):. PubMed ID: 29046370 [Abstract] [Full Text] [Related]
17. Dexamethasone regulation of cFos mRNA in osteoprogenitors. Shur I, Socher R, Benayahu D. J Cell Physiol; 2005 Jan 22; 202(1):240-5. PubMed ID: 15389524 [Abstract] [Full Text] [Related]
18. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S. Endocrinology; 1999 Oct 22; 140(10):4382-9. PubMed ID: 10499489 [Abstract] [Full Text] [Related]
19. Regulation of BMP-induced transcription in cultured human bone marrow stromal cells. Diefenderfer DL, Osyczka AM, Garino JP, Leboy PS. J Bone Joint Surg Am; 2003 Oct 22; 85-A Suppl 3():19-28. PubMed ID: 12925605 [Abstract] [Full Text] [Related]
20. Glucocorticoid regulation of alkaline phosphatase, osteocalcin, and proto-oncogenes in normal human osteoblast-like cells. Subramaniam M, Colvard D, Keeting PE, Rasmussen K, Riggs BL, Spelsberg TC. J Cell Biochem; 1992 Dec 22; 50(4):411-24. PubMed ID: 1469072 [Abstract] [Full Text] [Related] Page: [Next] [New Search]